Skip to main content

Day: April 29, 2025

TalentAlly and disABLEDperson Celebrate 10 Years of Partnership Empowering Job Seekers with Disabilities

CHICAGO, April 29, 2025 (GLOBE NEWSWIRE) — TalentAlly, a business unit of Professional Diversity Network, Inc. (NASDAQ: IPDN) and a leading provider of inclusive recruitment solutions and job board services in the United States, proudly celebrates the 10th anniversary of its partnership with disABLEDperson, Inc., one of the nation’s premier disability-focused job boards. Since forming the collaboration in 2014, TalentAlly and disABLEDperson have worked together to expand access to meaningful, rewarding employment opportunities for individuals with disabilities nationwide. As part of this longstanding commitment, TalentAlly actively promotes inclusive hiring through its dedicated platform, Ability Careers (www.abilitycareers.com), which has attracted nearly 20,000 users from the disability community over the past 12 months alone....

Continue reading

Kadant Reports First Quarter 2025 Results

WESTFORD, Mass., April 29, 2025 (GLOBE NEWSWIRE) — Kadant Inc. (NYSE: KAI) reported its financial results for the first quarter ended March 29, 2025. First Quarter Financial HighlightsBookings increased 3% to $256 million Revenue decreased 4% to $239 million Gross margin increased 150 basis points to 46.1% Net income decreased 3% to $24 million GAAP EPS decreased 3% to $2.04 Adjusted EPS decreased 12% to $2.10 Adjusted EBITDA decreased 8% to $48 million and represented 20.0% of revenue Operating cash flow remained flat at $23 million Free cash flow increased 15% to $19 millionNote: Percent changes above are based on comparison to the prior year period. All references to earnings per share (EPS) are to our EPS as calculated on a diluted basis. Adjusted EPS, adjusted EBITDA, adjusted EBITDA margin, free cash flow, and changes...

Continue reading

Nuvectis Pharma Provides Poster Presentation Highlights for NXP900 from the 2025 AACR Meeting

Phase 1a dose-escalation study data update: treatment with NXP900 resulted in exposure levels leading to robust pharmacodynamic responses across a range of tolerated doses; NXP900 has an acceptable safety profile, dose limiting toxicity dose level has not been identified in doses up to 250 mg/day Preclinical posters strengthen the NXP900 clinical development strategy as single agent in biomarker-targeted cancers and in combination with market leading therapies to overcome resistance in NSCLC Fort Lee, NJ, April 29, 2025 (GLOBE NEWSWIRE) — Nuvectis Pharma, Inc. (NASDAQ: NVCT) (“Nuvectis” or the “Company”), a clinical-stage biopharmaceutical company focused on the development of innovative precision medicines for the treatment of serious conditions of unmet medical need in oncology today provided poster presentation...

Continue reading

Silvaco Expands Product Offerings in Photonics and Wafer-Scale Plasma Modeling for AI Applications with Acquisition of Tech-X Corporation

SANTA CLARA, Calif., April 29, 2025 (GLOBE NEWSWIRE) — Silvaco Group, Inc. (Nasdaq: SVCO) (“Silvaco” or the “Company”), a provider of TCAD, EDA software and SIP solutions that enable semiconductor design and digital twin modeling through AI software and innovation, today announced the strategic acquisition of Tech-X Corporation, a leading provider of multi-physics simulation software used in applications such as Photonics, Electromagnetics and Plasma Dynamics. Tech-X cutting-edge tools enable:Multi-physics simulation of electromagnetic, and electrostatics in complex dielectric and metallic environments; Combination of computational speed leveraging GPUs, and high-fidelity results for Photonics applications; Plasma Dynamics simulation trusted by engineers and researchers in aerospace and semiconductor manufacturing; and Monte...

Continue reading

O-I Glass Reports First Quarter 2025 Results

PERRYSBURG, Ohio, April 29, 2025 (GLOBE NEWSWIRE) — FOR IMMEDIATE RELEASE                                                          Strong Start to 2025 as ‘Fit to Win’ Takes Hold Reaffirming Full Year 2025 GuidanceO-I Glass, Inc. (“O-I”) (NYSE: OI) today reported financial results for the first quarter ended March 31, 2025.  Net Earnings (Loss) Attributable to the Company Per Share (Diluted) Earnings Before Income Taxes$M1Q25 1Q24 1Q25 1Q24Reported ($0.10)                                        $0.45 $18 $117  Adjusted EarningsEarnings Per Share (Diluted) Segment Operating Profit$M1Q25 1Q24 1Q25 1Q24Non – GAAP $0.40 $0.45 (no adjustments reported) $209 $235“O-I demonstrated strong performance in the first quarter of 2025, as our ‘Fit to Win’ strategy takes hold and we make significant progress towards...

Continue reading

Orion Group Holdings Reports First Quarter 2025 Results

HOUSTON, April 29, 2025 (GLOBE NEWSWIRE) — Orion Group Holdings, Inc. (NYSE: ORN) (the “Company”), a leading specialty construction company, today reported its financial results for the first quarter ended March 31, 2025. Highlights for the quarter ended March 31, 2025:Contract revenues increased 17.4% to $188.7 million versus the prior year period GAAP net loss of $1.4 million or $0.04 per diluted share compared to a GAAP net loss of $6.1 million or $0.19 per diluted share year-over-year Adjusted net income of $0.3 million or $0.01 per diluted share versus Adjusted net loss of $3.6 million or $0.11 per diluted share in the first quarter last year Adjusted EBITDA increased 100.4% to $8.2 million compared to the prior year period New contract wins of $349 million year-to-date Contracted backlog and awards subsequent to quarter...

Continue reading

Artisan Partners Asset Management Inc. Reports 1Q25 Results

MILWAUKEE, April 29, 2025 (GLOBE NEWSWIRE) — Artisan Partners Asset Management Inc. (NYSE: APAM) (the “Company” or “Artisan Partners”) today reported its results for the three months ended March 31, 2025, and declared a quarterly dividend. The full March 2025 quarter earnings release and investor presentation can be viewed at www.apam.com. Conference Call The Company will host a conference call on April 30, 2025, at 1:00 p.m. (Eastern Time) to discuss its results for the three months ended March 31, 2025. Hosting the call will be Eric Colson, Chief Executive Officer, Jason Gottlieb, President, and C.J. Daley, Chief Financial Officer. Supplemental materials that will be reviewed during the call are available on the Company’s website at www.apam.com. The call will be webcast and can be accessed via the Company’s website. Listeners...

Continue reading

Blink Charging and Create Energy Launch Industry-First Turnkey Energy Storage Solution for On-Demand Grid Resiliency

The fully integrated solution combines EV charging, solar, and storage into a single, scalable product designed to reduce costs, boost performance, and address common challenges such as permitting delays and grid limitations, opening access to difficult or costly locations. Bowie, Md., April 29, 2025 (GLOBE NEWSWIRE) — Blink Charging Co. (NASDAQ: BLNK) (“Blink” or the “Company”), a leading global owner, operator, provider, and manufacturer of electric vehicle (EV) charging equipment and services, has teamed up with Create Energy to deliver a first-of-its-kind turnkey solution that combines energy storage, on-site generation, and EV charging to offer on-demand grid resiliency. This uniquely integrated system brings together Blink’s advanced L2 and DCFC chargers and Create Energy’s Nanogrid technology into a single, deployable package....

Continue reading

Facephi Ends 2024 Strong with Double-Digit Growth Across Key Metrics: TCV, ARR, Turnover and Ebitda

Facephi Ends 2024 Strong with Double-Digit Growth Across Key Metrics: TCV, ARR, Turnover and EbitdaTurnover reached €28.9mm, setting a new high with a 14.8% YoY growth, driven by the launch of new products and services, as well as ongoing diversification into new countries and business verticals. TCV1 and ARR2 also set new highs, reaching €57.8mm and €28.0mm, respectively, reflecting 49.5% and 28.5% growth compared to 2023; underscoring the Company’s positive outlook for 2025 and beyond. Normalized Ebitda reached €1.0mm; a favorable increase of 10.4% compared to €0.9mm in 2023. Both Cash Flow & Net Financial Debt saw significant improvements versus 2023 Facephi will host a webcast to discuss earnings on Wednesday, May 7, 2025, at 10:00 CT.Alicante, April 29th , 2025 – Facephi Biometría, SA (BME Growth: FACE; Euronext...

Continue reading

GENFIT Announces Publication of the 2024 Universal Registration Document and the 2024 Annual Report on Form 20-F

Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland), April 29, 2025 – GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today announces the filing of its 2024 Universal Registration Document with the Autorité des marches financiers (AMF ; filing n° D.25-0331) and its Annual Report on Form 20-F for the year ended December 31, 2024 with the U.S. Securities and Exchange Commission (SEC).  These annual reports are available to the public free of charge in accordance with applicable regulations and may be viewed at and downloaded from GENFIT’s website at ir.genfit.com. The 2024 Registration Document will also be available shortly on the AMF’s website: www.amf-france.org and the Annual Report on Form 20-F...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.